Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review

Nimkur Lohpon Tonga; Obebe Francis Ameh; Okoye Chukwuma; John Emmanuel

doi:doi:10.11648/j.ijcocr.20230801.11

| Peer-Reviewed

Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review

Nimkur Lohpon Tonga, Obebe Francis Ameh, Okoye Chukwuma, John Emmanuel

Published in International Journal of Clinical Oncology and Cancer Research (Volume 8, Issue 1)

Received: 8 September 2022 Accepted: 24 October 2022 Published: 20 March 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Introduction: Lymphomas are heterogeneous group of lymphoid tissues traditionally categorized as either Hodgkin’s Lymphoma (HL) or Non-Hodgkin’s Lymphoma (NHL). The head and neck region is rich in lymphoid tissues, thus a fertile anatomic site for the development of lymphoid proliferative diseases like lymphomas. In the head and neck, malignant lymphomas account for 5% of all malignant neoplasm; Non-Hodgkin’s Lymphoma (NHL) is the most common accounting for 75%. The clinical behaviour and manifestations of Lymphomas in the head and neck lack specific characteristics that would enable attribution to a specific lymphoma entity without biopsy and histological evidence. Materials and Methods: It is a 5 year retrospective study of confirmed histopathological analysis of head and neck lymphomas from 1^st January 2017 to31^st December 2021. Case notes of all histopathologically confirmed head and neck lymphomas were retrieved from the medical records department and also theatre records as supportive data were analysed for age, sex, histological diagnosis, tumour site, duration of symptoms before presentation and treatment modality; and then discussed. Results:-The total number of patients seen during the period under review was 1678, 16 patients had histopathologically confirmed lymphomas out of 388 patients with head and neck tumours, thus prevalence of 0.1% and 4.1% of all head and neck tumours. Male to Female ratio of 5:1, age range of 4 to 62 years, mean age of 29 years. Most common tumour site is the cervical region-315; the most frequently seen histological type is the Non Hodgkin’s lymphoma (NHL) and the most common duration of symptom before presentation is over 1 year-50%. All patients had chemotherapy as a treatment modality. Conclusion: This study reveals the management challenges of the head and neck lymphomas are due to late presentation, financial constraints and ignorance. Health awareness and adequate Health Insurance Policy are needed to cope or mitigate these problems.

Published in	International Journal of Clinical Oncology and Cancer Research (Volume 8, Issue 1)
DOI	10.11648/j.ijcocr.20230801.11
Page(s)	1-4
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Lymphoma, Non -Hodgkin’s, Hodgkin’s, Head and Neck Region

References

[1]	Kleihues P, Stewart BW, editors. 2003 world cancer report. Lymphoma. Lyon: International Agency for Research on Cancer Press, 2003: 237-41.
[2]	Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993; 43 (1): 7–26.
[3]	Mawardi H, Cutler C, Treister N. Medical management update: non-Hodgkin’s lymphoma. Oral Surg Oral med Oral Pathol Oral Radiol Oral. J Endod. 2009; 107 (1): 19–33.
[4]	Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. In: Bosman FT, Jaffe ES, Lakhani SR, Ohgaki H, editors. World Health Organization classification of Tumours. Lyon. France: IARC; 2008.
[5]	Swerdlow ST, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127 (20): 2375–90.
[6]	Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127 (20): 2391–405.
[7]	Harris NL, Jaffe ES, Stein H, et al. A revised European American classification of lymphoid neoplasm: a proposal from the international lymphoma study group. Blood. 1994; 84: 1361–92.
[8]	Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol. 1999; 111 (Suppl): 8–12.
[9]	Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am. 2003; 13: 371–92.
[10]	Sohani AR, Hasserjian RP. Diagnosis of Burkitt lymphoma and related high-grad B-cell neoplasms. Surg Pathol Clin. 2010; 3 (4): 1035–59.
[11]	Toader C, Toader M, Stoica A, Pop G, Oprea A, et al. Tonsillar lymphoma masquerading as obstructive sleep apnea -pediatric case report. Rom J Morphol Embryol. 2016; 57 (2 Suppl): 885–91.
[12]	Oluwasola AO, John AO, Jesse AO, Gabriel OO, et al. A Fifteen-year Review of Lymphomas in a Nigerian Tertiary Healthcare Centre. Journal of Health Population and Nutrition. 2011. 29 (4): 310-316.
[13]	Shamloo N, Ghannadan A, Jafari M, Ahmadi S, Mortazavi H, Baharvand M. Head and lymphoma in an Iranian population. Iran J Otorhinolarygol. 2017. 94: 262-267.
[14]	Alli N, Meer S. Head and neck lymphomas: A 20 year review in an oral pathology unit. Oral Oncol. 2017. 67: 17-23.
[15]	Roh JL, Huh J, Moon HN. Lymphomas of the head and neck in the paediatric population. Int J Pediatr Otorhinolaryngol. 71 (9): 1471-7.
[16]	GOOGLE: https://www.webmd.com>...>Leukemia and Lymphoma. Lymphoma: Definition, Symptoms, Causes, Diagnosis… 4 mar 2022.

Cite This Article

Plain Text BibTeX RIS

APA Style

Nimkur Lohpon Tonga, Obebe Francis Ameh, Okoye Chukwuma, John Emmanuel. (2023). Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review. International Journal of Clinical Oncology and Cancer Research, 8(1), 1-4. https://doi.org/10.11648/j.ijcocr.20230801.11

Copy | Download

ACS Style

Nimkur Lohpon Tonga; Obebe Francis Ameh; Okoye Chukwuma; John Emmanuel. Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review. Int. J. Clin. Oncol. Cancer Res. 2023, 8(1), 1-4. doi: 10.11648/j.ijcocr.20230801.11

Copy | Download

AMA Style

Nimkur Lohpon Tonga, Obebe Francis Ameh, Okoye Chukwuma, John Emmanuel. Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review. Int J Clin Oncol Cancer Res. 2023;8(1):1-4. doi: 10.11648/j.ijcocr.20230801.11

Copy | Download

@article{10.11648/j.ijcocr.20230801.11,
  author = {Nimkur Lohpon Tonga and Obebe Francis Ameh and Okoye Chukwuma and John Emmanuel},
  title = {Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review},
  journal = {International Journal of Clinical Oncology and Cancer Research},
  volume = {8},
  number = {1},
  pages = {1-4},
  doi = {10.11648/j.ijcocr.20230801.11},
  url = {https://doi.org/10.11648/j.ijcocr.20230801.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20230801.11},
  abstract = {Introduction: Lymphomas are heterogeneous group of lymphoid tissues traditionally categorized as either Hodgkin’s Lymphoma (HL) or Non-Hodgkin’s Lymphoma (NHL). The head and neck region is rich in lymphoid tissues, thus a fertile anatomic site for the development of lymphoid proliferative diseases like lymphomas. In the head and neck, malignant lymphomas account for 5% of all malignant neoplasm; Non-Hodgkin’s Lymphoma (NHL) is the most common accounting for 75%. The clinical behaviour and manifestations of Lymphomas in the head and neck lack specific characteristics that would enable attribution to a specific lymphoma entity without biopsy and histological evidence. Materials and Methods: It is a 5 year retrospective study of confirmed histopathological analysis of head and neck lymphomas from 1st January 2017 to31st December 2021. Case notes of all histopathologically confirmed head and neck lymphomas were retrieved from the medical records department and also theatre records as supportive data were analysed for age, sex, histological diagnosis, tumour site, duration of symptoms before presentation and treatment modality; and then discussed. Results:-The total number of patients seen during the period under review was 1678, 16 patients had histopathologically confirmed lymphomas out of 388 patients with head and neck tumours, thus prevalence of 0.1% and 4.1% of all head and neck tumours. Male to Female ratio of 5:1, age range of 4 to 62 years, mean age of 29 years. Most common tumour site is the cervical region-315; the most frequently seen histological type is the Non Hodgkin’s lymphoma (NHL) and the most common duration of symptom before presentation is over 1 year-50%. All patients had chemotherapy as a treatment modality. Conclusion: This study reveals the management challenges of the head and neck lymphomas are due to late presentation, financial constraints and ignorance. Health awareness and adequate Health Insurance Policy are needed to cope or mitigate these problems.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review
AU  - Nimkur Lohpon Tonga
AU  - Obebe Francis Ameh
AU  - Okoye Chukwuma
AU  - John Emmanuel
Y1  - 2023/03/20
PY  - 2023
N1  - https://doi.org/10.11648/j.ijcocr.20230801.11
DO  - 10.11648/j.ijcocr.20230801.11
T2  - International Journal of Clinical Oncology and Cancer Research
JF  - International Journal of Clinical Oncology and Cancer Research
JO  - International Journal of Clinical Oncology and Cancer Research
SP  - 1
EP  - 4
PB  - Science Publishing Group
SN  - 2578-9511
UR  - https://doi.org/10.11648/j.ijcocr.20230801.11
AB  - Introduction: Lymphomas are heterogeneous group of lymphoid tissues traditionally categorized as either Hodgkin’s Lymphoma (HL) or Non-Hodgkin’s Lymphoma (NHL). The head and neck region is rich in lymphoid tissues, thus a fertile anatomic site for the development of lymphoid proliferative diseases like lymphomas. In the head and neck, malignant lymphomas account for 5% of all malignant neoplasm; Non-Hodgkin’s Lymphoma (NHL) is the most common accounting for 75%. The clinical behaviour and manifestations of Lymphomas in the head and neck lack specific characteristics that would enable attribution to a specific lymphoma entity without biopsy and histological evidence. Materials and Methods: It is a 5 year retrospective study of confirmed histopathological analysis of head and neck lymphomas from 1st January 2017 to31st December 2021. Case notes of all histopathologically confirmed head and neck lymphomas were retrieved from the medical records department and also theatre records as supportive data were analysed for age, sex, histological diagnosis, tumour site, duration of symptoms before presentation and treatment modality; and then discussed. Results:-The total number of patients seen during the period under review was 1678, 16 patients had histopathologically confirmed lymphomas out of 388 patients with head and neck tumours, thus prevalence of 0.1% and 4.1% of all head and neck tumours. Male to Female ratio of 5:1, age range of 4 to 62 years, mean age of 29 years. Most common tumour site is the cervical region-315; the most frequently seen histological type is the Non Hodgkin’s lymphoma (NHL) and the most common duration of symptom before presentation is over 1 year-50%. All patients had chemotherapy as a treatment modality. Conclusion: This study reveals the management challenges of the head and neck lymphomas are due to late presentation, financial constraints and ignorance. Health awareness and adequate Health Insurance Policy are needed to cope or mitigate these problems.
VL  - 8
IS  - 1
ER  -

Copy | Download

Author Information

Nimkur Lohpon Tonga

Department of Otorhinolaryngology, Head and Neck Surgery Jos University Teaching Hospital, Jos, Nigeria
Obebe Francis Ameh

Department of Otorhinolaryngology, Head and Neck Surgery Jos University Teaching Hospital, Jos, Nigeria
Okoye Chukwuma

Department of Otorhinolaryngology, Head and Neck Surgery Jos University Teaching Hospital, Jos, Nigeria
John Emmanuel

Department of Surgery, Ear, Nose and Throat (Otorhinolaryngology) Unit Federal Medical Centre Keffi, Keffi, Nigeria

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Nimkur Lohpon Tonga, Obebe Francis Ameh, Okoye Chukwuma, John Emmanuel. (2023). Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review. International Journal of Clinical Oncology and Cancer Research, 8(1), 1-4. https://doi.org/10.11648/j.ijcocr.20230801.11

Copy | Download

ACS Style

Nimkur Lohpon Tonga; Obebe Francis Ameh; Okoye Chukwuma; John Emmanuel. Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review. Int. J. Clin. Oncol. Cancer Res. 2023, 8(1), 1-4. doi: 10.11648/j.ijcocr.20230801.11

Copy | Download

AMA Style

Nimkur Lohpon Tonga, Obebe Francis Ameh, Okoye Chukwuma, John Emmanuel. Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review. Int J Clin Oncol Cancer Res. 2023;8(1):1-4. doi: 10.11648/j.ijcocr.20230801.11

Copy | Download

@article{10.11648/j.ijcocr.20230801.11,
  author = {Nimkur Lohpon Tonga and Obebe Francis Ameh and Okoye Chukwuma and John Emmanuel},
  title = {Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review},
  journal = {International Journal of Clinical Oncology and Cancer Research},
  volume = {8},
  number = {1},
  pages = {1-4},
  doi = {10.11648/j.ijcocr.20230801.11},
  url = {https://doi.org/10.11648/j.ijcocr.20230801.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20230801.11},
  abstract = {Introduction: Lymphomas are heterogeneous group of lymphoid tissues traditionally categorized as either Hodgkin’s Lymphoma (HL) or Non-Hodgkin’s Lymphoma (NHL). The head and neck region is rich in lymphoid tissues, thus a fertile anatomic site for the development of lymphoid proliferative diseases like lymphomas. In the head and neck, malignant lymphomas account for 5% of all malignant neoplasm; Non-Hodgkin’s Lymphoma (NHL) is the most common accounting for 75%. The clinical behaviour and manifestations of Lymphomas in the head and neck lack specific characteristics that would enable attribution to a specific lymphoma entity without biopsy and histological evidence. Materials and Methods: It is a 5 year retrospective study of confirmed histopathological analysis of head and neck lymphomas from 1st January 2017 to31st December 2021. Case notes of all histopathologically confirmed head and neck lymphomas were retrieved from the medical records department and also theatre records as supportive data were analysed for age, sex, histological diagnosis, tumour site, duration of symptoms before presentation and treatment modality; and then discussed. Results:-The total number of patients seen during the period under review was 1678, 16 patients had histopathologically confirmed lymphomas out of 388 patients with head and neck tumours, thus prevalence of 0.1% and 4.1% of all head and neck tumours. Male to Female ratio of 5:1, age range of 4 to 62 years, mean age of 29 years. Most common tumour site is the cervical region-315; the most frequently seen histological type is the Non Hodgkin’s lymphoma (NHL) and the most common duration of symptom before presentation is over 1 year-50%. All patients had chemotherapy as a treatment modality. Conclusion: This study reveals the management challenges of the head and neck lymphomas are due to late presentation, financial constraints and ignorance. Health awareness and adequate Health Insurance Policy are needed to cope or mitigate these problems.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Head and Neck Lymphomas in Jos University Teaching Hospital Nigeria: A Five Year Review
AU  - Nimkur Lohpon Tonga
AU  - Obebe Francis Ameh
AU  - Okoye Chukwuma
AU  - John Emmanuel
Y1  - 2023/03/20
PY  - 2023
N1  - https://doi.org/10.11648/j.ijcocr.20230801.11
DO  - 10.11648/j.ijcocr.20230801.11
T2  - International Journal of Clinical Oncology and Cancer Research
JF  - International Journal of Clinical Oncology and Cancer Research
JO  - International Journal of Clinical Oncology and Cancer Research
SP  - 1
EP  - 4
PB  - Science Publishing Group
SN  - 2578-9511
UR  - https://doi.org/10.11648/j.ijcocr.20230801.11
AB  - Introduction: Lymphomas are heterogeneous group of lymphoid tissues traditionally categorized as either Hodgkin’s Lymphoma (HL) or Non-Hodgkin’s Lymphoma (NHL). The head and neck region is rich in lymphoid tissues, thus a fertile anatomic site for the development of lymphoid proliferative diseases like lymphomas. In the head and neck, malignant lymphomas account for 5% of all malignant neoplasm; Non-Hodgkin’s Lymphoma (NHL) is the most common accounting for 75%. The clinical behaviour and manifestations of Lymphomas in the head and neck lack specific characteristics that would enable attribution to a specific lymphoma entity without biopsy and histological evidence. Materials and Methods: It is a 5 year retrospective study of confirmed histopathological analysis of head and neck lymphomas from 1st January 2017 to31st December 2021. Case notes of all histopathologically confirmed head and neck lymphomas were retrieved from the medical records department and also theatre records as supportive data were analysed for age, sex, histological diagnosis, tumour site, duration of symptoms before presentation and treatment modality; and then discussed. Results:-The total number of patients seen during the period under review was 1678, 16 patients had histopathologically confirmed lymphomas out of 388 patients with head and neck tumours, thus prevalence of 0.1% and 4.1% of all head and neck tumours. Male to Female ratio of 5:1, age range of 4 to 62 years, mean age of 29 years. Most common tumour site is the cervical region-315; the most frequently seen histological type is the Non Hodgkin’s lymphoma (NHL) and the most common duration of symptom before presentation is over 1 year-50%. All patients had chemotherapy as a treatment modality. Conclusion: This study reveals the management challenges of the head and neck lymphomas are due to late presentation, financial constraints and ignorance. Health awareness and adequate Health Insurance Policy are needed to cope or mitigate these problems.
VL  - 8
IS  - 1
ER  -

Copy | Download